Diabetes Med Access May Be Better for Commercial Patients With Chart: Commercial, Medicare Advantage Enrollees Use Diabetes Drugs Differently
A new study published in JAMA Network Open suggests commercial insurance members have better access to newer diabetes drugs than members of Medicare Advantage plans — especially MA members with low incomes.
“Better understanding of nonclinical factors contributing to treatment decisions and efforts to promote greater equity in diabetes management appear to be needed,” the study concluded.
© 2022 MMIT